Late Wednesday evening, Oct. 15, Yale New Haven Hospital admitted a patient who met the threshold to be monitored for Ebola Virus Disease (EVD). The hospital is working with the Centers for Disease Control and Prevention (CDC) and the Connecticut Department of Public Health to have the patient tested for EVD. The hospital is currently overseeing operations related to the monitoring and care of the patient.
The hospital has been actively monitoring the Ebola virus situation and has procedures in place to detect and isolate any patient showing symptoms of the disease. Yale New Haven has advanced equipment and facilities and a staff well trained to treat any patient with Ebola, and holds regular drills to address situations such as infectious disease outbreaks.
Very few people are at risk of contracting Ebola. It is transmitted only by direct contact with the blood or body fluids of an infected patient showing active symptoms (fever over 101.5°F, severe headache, muscle pain, weakness, diarrhea, vomiting, stomach pain, unexplained bleeding or bruising). Patients, families and visitors should continue to come to the hospital and their doctors’ offices for care without fear of being exposed to Ebola virus.
Yale New Haven Hospital employs protection measures even greater than those recommended by the CDC. If a patient with Ebola symptoms comes to the hospital, he or she would be isolated from other patients and cared for in a special isolation room. Staff caring for patients with infectious diseases like Ebola wear protective gear, such as masks, face shields, gloves, protective gowns or suits and other equipment.
Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org
5/30/2023
Smilow Cancer Hospital Receives $50,000 from the American Cancer Society to Provide Transportation and Lodging Support for Patients Undergoing Cancer Treatment(New Haven, CT, May 30, 2023) – Smilow Cancer Hospital at Yale New Haven has been awarded a $50,000 transportation and lodging grant by the American Cancer Society (ACS) to alleviate the financial burden of cancer treatment.
5/25/2023
Johnson & Johnson Nursing Innovation Fellowship Program selects two Yale New Haven Hospital nurse leadersNew Haven, CT (May 25, 2023) – The University of Pennsylvania School of Nursing has announced ten teams from health systems around the country have been selected for the Johnson & Johnson Nurse Innovation Fellowship Program (JJNIF), powered by Penn Nursing and the Wharton School – a ground-breaking, one-year, team-based nursing fellowship for chief nursing officers (CNO), nurse executives, and senior nurse leaders. Ena Williams, PhD, RN, senior vice president and CNO at Yale New Haven Hospital and Jeannette Bronsord, DNP, executive director, surgical services at YNHH, have been selected.
5/3/2023
Yale New Haven Health ranks 20th on the DiversityInc 2023 Top 50 Companies ListYale New Haven Health System (YNHHS) has been ranked 20th on the 2023 DiversityInc Top 50 Hospital and Health System for Diversity list.